Whan In Pharm Co.,Ltd. (KRX:016580)

Market Cap	170.38B -6.6%
Revenue (ttm)	256.32B +1.8%
Net Income	15.17B -44.6%
EPS	978.53 -45.4%
Shares Out	15.27M
PE Ratio	11.40
Forward PE	11.63
Dividend	300.00 (2.72%)
Ex-Dividend Date	Dec 29, 2025

Volume	68,975
Average Volume	62,334
Open	11,010
Previous Close	11,010
Day's Range	10,970 - 11,220
52-Week Range	10,050 - 13,210
Beta	0.13
RSI	65.75
Earnings Date	Feb 13, 2026

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 601
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.